secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2025-02-14T23:59:59+00:00
Accession:  0000950170-25-021365
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Iterum Therapeutics loses audit committee compliance after Chairman Ronald Hunt resigns
--------------------------------------------------------------------------------

- Chairman Ronald Hunt resigned Feb 14, 2025, ending 9+ year tenure; no dispute with board.
- Vacancy on Audit Committee triggers non-compliance with Nasdaq Listing Rule 5605(c)(2)(A).
- Company notified Nasdaq same day; faces potential delisting if compliance not restored.
- Hunt also served on compensation, nominating, and governance committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000095017025021365/0000950170-25-021365-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000095017025021365/itrm-20250214.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-021365

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer